0121 ECP SciNeuro
BioCentury & Getty Images

Emerging Company Profile

SciNeuro reunites GSK R&D vets to bring CNS therapies to China 

Emerging Company Profile: SciNeuro to build neurodegeneration, neuropsychiatric pipeline via partnering, in-house R&D

Founder and CEO Min Li discusses the company’s partnering and R&D strategy.

Jan 22, 2021 | 1:19 AM GMT

Led by GSK neuro R&D alumni

Read the full 555 word article

How to gain access

Continue reading with a
two-week free trial.